Elevation of phospholipase C-β1 expression by amyloid-β facilitates calcium overload in neuronal cells

[1]  Razi Ahmad,et al.  Alzheimer's disease and its treatment by different approaches: A review. , 2021, European journal of medicinal chemistry.

[2]  D. Dickson,et al.  The neuropathological diagnosis of Alzheimer’s disease , 2019, Molecular Neurodegeneration.

[3]  K. Myers.  PLCB1 Biallelic Point Mutations Cause West Syndrome. , 2019, Pediatric neurology.

[4]  K. Cheung,et al.  Calcium signaling in Alzheimer's disease & therapies. , 2018, Biochimica et biophysica acta. Molecular cell research.

[5]  I. Bezprozvanny,et al.  Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease. , 2018, Antioxidants & redox signaling.

[6]  M. Stecker,et al.  Amyloid toxicity in Alzheimer’s disease , 2018, Reviews in the neurosciences.

[7]  M. Mesulam,et al.  The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. , 2018, Brain : a journal of neurology.

[8]  S. Scarlata,et al.  Phospholipase Cb1 regulates proliferation of neuronal cells , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Sangyun Jeong,et al.  Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease , 2017, Molecules and cells.

[10]  A. Hannan,et al.  Isoform specific differences in phospholipase C beta 1 expression in the prefrontal cortex in schizophrenia and suicide , 2017, npj Schizophrenia.

[11]  Josiah R. Boivin,et al.  Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain , 2017, Molecular Neurodegeneration.

[12]  Z. Khachaturian,et al.  Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.

[13]  Jung-Mi Hah,et al.  Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice , 2016, EMBO molecular medicine.

[14]  J. Dorszewska,et al.  Molecular Basis of Familial and Sporadic Alzheimer's Disease. , 2016, Current Alzheimer research.

[15]  T. Rohacs.  Phosphoinositide signaling in somatosensory neurons. , 2016, Advances in biological regulation.

[16]  U. Sengupta,et al.  The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy , 2016, EBioMedicine.

[17]  T. H. Ferreira-Vieira,et al.  Alzheimer's Disease: Targeting the Cholinergic System , 2016, Current neuropharmacology.

[18]  Sukchan Lee,et al.  Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia , 2015, Front. Psychiatry.

[19]  Sagar H. Barage,et al.  Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease , 2015, Neuropeptides.

[20]  K. Stover,et al.  Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease , 2015, Behavioural Brain Research.

[21]  Xinglong Wang,et al.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[22]  F. Roman,et al.  Onset of hippocampus‐dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease , 2014, Hippocampus.

[23]  Arthur Christopoulos,et al.  Muscarinic acetylcholine receptors: novel opportunities for drug development , 2014, Nature Reviews Drug Discovery.

[24]  I. Parker,et al.  Cytotoxicity of Intracellular Aβ42 Amyloid Oligomers Involves Ca2+ Release from the Endoplasmic Reticulum by Stimulated Production of Inositol Trisphosphate , 2013, The Journal of Neuroscience.

[25]  L. Mucke,et al.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.

[26]  J. Jhamandas,et al.  Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain , 2012, Expert Reviews in Molecular Medicine.

[27]  V. L. Vasco,et al.  Deletion of PLCB1 gene in schizophrenia-affected patients , 2011, Journal of cellular and molecular medicine.

[28]  I. Scheffer,et al.  Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. , 2010, Brain : a journal of neurology.

[29]  T. Suuronen,et al.  ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology , 2009, Journal of Neuroinflammation.

[30]  V. Vingtdeux,et al.  Calcium signaling in neurodegeneration , 2009, Molecular Neurodegeneration.

[31]  M. Ohno,et al.  Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model , 2009, Neurobiology of Disease.

[32]  Masahiko Watanabe,et al.  Predominant expression of phospholipase Cβ1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements , 2008, The European journal of neuroscience.

[33]  R. Resende,et al.  Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death , 2008, Neuroscience.

[34]  Kim N. Green,et al.  Linking Calcium to Aβ and Alzheimer's Disease , 2008, Neuron.

[35]  D. Alkon,et al.  Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. , 2008, European journal of pharmacology.

[36]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[37]  S. G. Lechner,et al.  Presynaptic Inhibition via a Phospholipase C- and Phosphatidylinositol Bisphosphate-Dependent Regulation of Neuronal Ca2+ Channels , 2005, Molecular Pharmacology.

[38]  C. Blakemore,et al.  Activity-dependent Regulation of Synapse and Dendritic Spine Morphology in Developing Barrel Cortex Requires Phospholipase C-β1 Signalling , 2005 .

[39]  Wendy W. Wu,et al.  Biophysical alterations of hippocampal pyramidal neurons in learning, ageing and Alzheimer's disease , 2004, Ageing Research Reviews.

[40]  C. Oliveira,et al.  Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1,4,5‐triphosphate receptors in the neurotoxic effects induced by the amyloid‐β peptide , 2004, Journal of neuroscience research.

[41]  M. Duchen,et al.  β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase , 2004, The Journal of Neuroscience.

[42]  F. LaFerla.  Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.

[43]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[44]  P. Marie,et al.  Activation of Phospholipase C-β1 via Gαq/11during Calcium Mobilization by Calcitonin Gene-related Peptide* , 1998, The Journal of Biological Chemistry.

[45]  S. Ryu,et al.  Phospholipase C isozymes selectively couple to specific neurotransmitter receptors , 1997, Nature.

[46]  H. Loh,et al.  U73122 inhibits phospholipase C-dependent calcium mobilization in neuronal cells , 1994, Brain Research.

[47]  K. Suzuki,et al.  Tissue- and cell type-specific expression of mRNAs for four types of inositol phospholipid-specific phospholipase C. , 1989, Biochemical and biophysical research communications.

[48]  S. Y. Lee,et al.  Studies of inositol phospholipid-specific phospholipase C. , 1989, Science.

[49]  O. Krishtal,et al.  Effects of calcium and calcium‐chelating agents on the inward and outward current in the membrane of mollusc neurones , 1977, The Journal of physiology.

[50]  G. García del Caño,et al.  Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons. , 2014, Advances in biological regulation.

[51]  W. Müller,et al.  Disturbances of the neuronal calcium homeostasis in the aging nervous system. , 1994, Life sciences.